Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Drug Class

  2.3.2 Market Size By Disease Type

  2.3.3 Market Size By Route of Administration

  2.3.4 Market Size By Distribution Channel

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Epidemiology & Demand Indicators

4.1.1 Prevalence (%) of gastroparesis across diabetic and non-diabetic populations.

4.1.2 Incidence growth (%) linked to rising diabetes and obesity rates.

4.1.3 Diagnosis rate (%) vs. undiagnosed or misdiagnosed cases.

4.1.4 Patient pool distribution (%) across severity levels (mild, moderate, severe).

4.1.5 Treatment-seeking rate (%) among symptomatic patients.

4.2 Treatment & Clinical Outcomes Metrics

4.2.1 Symptom relief efficacy (%) across different therapeutic approaches.

4.2.2 Gastric emptying improvement (%) measured through clinical studies.

4.2.3 Hospitalization reduction (%) due to effective drug management.

4.2.4 Relapse/refractory rate (%) among treated patients.

4.2.5 Adverse event incidence (%) associated with long-term drug use.

4.3 Drug Development & Innovation Metrics

4.3.1 Number of pipeline drugs in clinical trials for gastroparesis.

4.3.2 Share (%) of novel mechanism-based therapies under development.

4.3.3 FDA/EMA approvals and orphan drug designations (%) in this segment.

4.3.4 R&D investment growth (%) by pharmaceutical companies.

4.3.5 Adoption (%) of personalized medicine and biomarker-driven treatment approaches.

4.4 Market & Competitive Landscape Insights

4.4.1 Market share (%) concentration among leading pharmaceutical players.

4.4.2 Pricing trends (%) across branded vs. generic therapies.

4.4.3 Penetration (%) of combination therapies vs. monotherapy.

4.4.4 Geographic expansion (%) in emerging vs. developed markets.

4.4.5 Strategic collaborations, licensing deals, and partnerships (%) in drug development.

5. Gastroparesis Drug Market Segmental Analysis & Forecast, By Drug Class, 2022 – 2035, Value (USD Billion)

5.1 Introduction

 5.2 Prokinetic Agents

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022 – 2035

 5.3 Antiemetic Drugs

 5.4 Motilin Receptor Agonists

    5.5 Dopamine Receptor Antagonists

    5.6 Serotonin (5-HT4) Receptor Agonists

    5.7 Ghrelin Agonists

    5.8 Others

6. Gastroparesis Drug Market Segmental Analysis & Forecast, By Disease Type, 2022 – 2035, Value (USD Billion)

    6.1 Introduction

 6.2 Diabetic Gastroparesis

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022 – 2035

     6.3 Idiopathic Gastroparesis

     6.4 Post-surgical Gastroparesis

     6.5 Others

7. Gastroparesis Drug Market Segmental Analysis & Forecast, By Route of Administration, 2022 – 2035, Value (USD Billion)

    7.1 Introduction

 7.2 Oral

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022 – 2035

 7.3 Injectable

     7.4 Others

8. Gastroparesis Drug Market Segmental Analysis & Forecast, By Distribution Channel, 2022 – 2035, Value (USD Billion)

    8.1 Introduction

 8.2 Hospital Pharmacies

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022 – 2035

     8.3 Retail Pharmacies

     8.4 Online Pharmacies

9. Gastroparesis Drug Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Gastroparesis Drug Market Size & Forecast, By Drug Class, 2022 – 2035

 9.2.3 Gastroparesis Drug Market Size & Forecast, By Disease Type, 2022 – 2035

 9.2.4 Gastroparesis Drug Market Size & Forecast, By Route of Administration, 2022 – 2035

 9.2.5 Gastroparesis Drug Market Size & Forecast, By Distribution Channel, 2022 – 2035

 9.2.6 Gastroparesis Drug Market Size & Forecast, By Country, 2022 – 2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Gastroparesis Drug Market Size & Forecast, By Drug Class, 2022 – 2035

 9.3.3 Gastroparesis Drug Market Size & Forecast, By Disease Type, 2022 – 2035

 9.3.4 Gastroparesis Drug Market Size & Forecast, By Route of Administration, 2022 – 2035

 9.3.5 Gastroparesis Drug Market Size & Forecast, By Distribution Channel, 2022 – 2035

 9.3.6 Gastroparesis Drug Market Size & Forecast, By Country, 2022 – 2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Gastroparesis Drug Market Size & Forecast, By Drug Class, 2022 – 2035

 9.4.3 Gastroparesis Drug Market Size & Forecast, By Disease Type, 2022 – 2035

 9.4.4 Gastroparesis Drug Market Size & Forecast, By Route of Administration, 2022 – 2035

 9.4.5 Gastroparesis Drug Market Size & Forecast, By Distribution Channel, 2022 – 2035

 9.4.6 Gastroparesis Drug Market Size & Forecast, By Country, 2022 – 2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Gastroparesis Drug Market Size & Forecast, By Drug Class, 2022 – 2035

 9.5.3 Gastroparesis Drug Market Size & Forecast, By Disease Type, 2022 – 2035

 9.5.4 Gastroparesis Drug Market Size & Forecast, By Route of Administration, 2022 – 2035

 9.5.5 Gastroparesis Drug Market Size & Forecast, By Distribution Channel, 2022 – 2035

 9.5.6 Gastroparesis Drug Market Size & Forecast, By Country, 2022 – 2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Gastroparesis Drug Market Size & Forecast, By Drug Class, 2022 – 2035

 9.6.3 Gastroparesis Drug Market Size & Forecast, By Disease Type, 2022 – 2035

 9.6.4 Gastroparesis Drug Market Size & Forecast, By Route of Administration, 2022 – 2035

 9.6.5 Gastroparesis Drug Market Size & Forecast, By Distribution Channel, 2022 – 2035

 9.6.6 Gastroparesis Drug Market Size & Forecast, By Country, 2022 – 2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 Egypt

  9.6.6.5 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022 – 2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Network Type Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Network Type Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

10.6.1 Evoke Pharma

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Product/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

10.6.2 Vanda Pharmaceuticals

10.6.3 Neurogastrx

10.6.4 Motus Therapeutics

10.6.5 Takeda Pharmaceutical Company

10.6.6 AbbVie

10.6.7 Ironwood Pharmaceuticals

10.6.8 Astellas Pharma

10.6.9 Amgen

10.6.10 Novartis

10.6.11 Pfizer

10.6.12 Merck & Co.

10.6.13 Johnson & Johnson

10.6.14 GlaxoSmithKline

10.6.15 Sanofi

10.6.16 Bayer AG

10.6.17 Eli Lilly and Company

10.6.18 Bristol-Myers Squibb

10.6.19 Otsuka Pharmaceutical

10.6.20 Zeria Pharmaceutical

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures